Esperanza Arias-Perez, Pharm.D., Ph.D., assistant professor of medicine and of pathology at Einstein, has been named a 2023 Keystone Symposia Fellow. She is one of only 10 investigators nationwide selected for the honor, which recognizes rising talent in biological and biomedical research.
The competitive one-year program is designed to provide early-career researchers from underrepresented and other disadvantaged backgrounds with the skills they need to successfully pursue leadership and decision-making roles in academic, industry, and government research sectors.
Dr. Arias-Perez received her Ph.D. from the School of Medicine at the Autonomous University of Madrid (Spain) and has worked in clinical research at Ferring Pharmaceuticals and at Pfizer. As a Fulbright postdoctoral fellow in the lab of Ana Maria Cuervo, M.D., Ph.D., professor of developmental and molecular biology and of medicine at Einstein, Dr. Arias-Perez studied mammalian autophagy in the context of aging and age-related diseases.
Esperanza Arias-Perez, Pharm.D., Ph.D. 
